Study objectives: To investigate the clinical, epidemiologic, and microbiol
ogical characteristics of community-acquired pneumonia (CAP) due to Acineto
bacter baumannii.
Methods: Retrospective chart and radiographic reviews of all patients who w
ere admitted to National Taiwan University Hospital from January 1993 to Au
gust 1999, fulfilled the criteria for CAP, and had an isolate of A baumanni
i from blood or pleural fluid at hospital admission.
Results: Thirteen patients (9 men and 4 women; age range, 37 to 85 years) m
et the criteria. Conditions associated with the infection included male gen
der, old age, alcoholism, malignancy, cerebrovascular disease, diabetes mel
litus, renal disease, and liver cirrhosis. Eleven patients (85%) acquired t
he infection during the warmer months of April to October. Twelve patients
(92%) had a fulminant course presenting with septic shock and respiratory f
ailure, and 11 patients (85%) needed ventilator support and were treated in
an ICU. Six patients (46%) had leukopenia. Lobar consolidations were found
in 12 patients (92%), and pleural effusions were present in 4 patients (31
%). All patients had positive blood culture results, two patients (15%) had
positive pleural effusion culture findings, and nine patients (69%) positi
ve sputum culture results. All the isolates were susceptible to imipenem, a
nd most were susceptible to aminoglycosides, ceftazidime, ciprofloxacin, an
d extended-spectrum penicillins. Eight patients (62%) died. Four of the fiv
e survivors were initially treated with combination of a third-generation c
ephalosporin and an aminoglycoside.
Conclusion: A baumannii should be considered as a possible etiologic agent
in community-acquired lobar pneumonia when (1) patients with a fulminant co
urse present during the warmer and more humid months of the year, and (2) p
atients are younger alcoholics. A good sputum smear, defined as a Gram stai
n smear of an adequate sputum specimen that comes from the lower respirator
y tract and contains > 25 leukocytes per high-power (100x) field on microsc
opic examination, can help early diagnosis and treatment. A combination of
a third-generation cephalosporin and an aminoglycoside may be appropriate e
mpirical therapy.